Chronic Myeloproliferative Disorders

Showing 51 - 75 of 123

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Cancer, Chronic Myeloproliferative Disorders, GTD Trial in Detroit (Aprepitant, Cyclophosphamide, Dexamethasone)

Completed
  • Breast Cancer
  • +11 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Feb 12, 2016

Chronic Myeloproliferative Disorders, Secondary Myelofibrosis Trial in Rochester (Dacogen)

Terminated
  • Chronic Myeloproliferative Disorders
  • Secondary Myelofibrosis
  • Rochester, Minnesota
    Mayo Clinic
Nov 25, 2015

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Duarte (behavioral, dietary supplement, other, procedure)

Completed
  • Chronic Myeloproliferative Disorders
  • +7 more
  • exercise intervention
  • +11 more
  • Duarte, California
    City of Hope Comprehensive Cancer Center
Jun 3, 2015

Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Duarte (cytology specimen collection procedure,

Terminated
  • Brain and Central Nervous System Tumors
  • +9 more
  • cytology specimen collection procedure
  • +2 more
  • Duarte, California
    City of Hope Comprehensive Cancer Center
Jun 3, 2015

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Duarte (drug, procedure, radiation)

Terminated
  • Chronic Myeloproliferative Disorders
  • +5 more
  • fludarabine phosphate
  • +6 more
  • Duarte, California
    City of Hope Comprehensive Cancer Center
Jun 3, 2015

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial (drug, genetic, other, procedure)

Completed
  • Chronic Myeloproliferative Disorders
  • +6 more
  • (no location specified)
Jun 3, 2015

Perceptions of Burden in Late-Stage Cancer and Their Caregivers

Withdrawn
  • Brain and Central Nervous System Tumors
  • +9 more
  • medical chart review
  • +2 more
  • (no location specified)
May 27, 2015

Donor-Derived DNA in Semen Samples From Cancer Survivors Who

Terminated
  • Cancer Survivor
  • +8 more
  • DNA analysis
  • +3 more
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Dec 8, 2014

Chronic Myeloproliferative Disorders, Leukemia, MDS Trial in United States (ruxolitinib phosphate, laboratory biomarker

Completed
  • Chronic Myeloproliferative Disorders
  • +4 more
  • ruxolitinib phosphate
  • +2 more
  • Birmingham, Alabama
  • +23 more
Oct 22, 2014

Chronic Myeloproliferative Disorders, Leukemia Trial in Jacksonville, Rochester, Houston (PS-341)

Completed
  • Chronic Myeloproliferative Disorders
  • Leukemia
  • Jacksonville, Florida
  • +2 more
Oct 15, 2014

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Indianapolis (cilengitide)

Completed
  • Chronic Myeloproliferative Disorders
  • +7 more
  • Indianapolis, Indiana
    Indiana University Cancer Center
Sep 16, 2014

Chronic Myeloproliferative Disorders, GVHD, Infection Trial in Phoenix, Duarte (biological, drug, procedure, radiation)

Completed
  • Chronic Myeloproliferative Disorders
  • +10 more
  • anti-thymocyte globulin
  • +12 more
  • Phoenix, Arizona
  • +1 more
Sep 3, 2014

Breast Cancer, Chronic Myeloproliferative Disorders, GTD Trial in Indianapolis (recombinant interleukin-12)

Completed
  • Breast Cancer
  • +10 more
  • recombinant interleukin-12
  • Indianapolis, Indiana
    Indiana University Cancer Center
Sep 9, 2014

Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Worldwide (filgrastim, allogeneic bone marrow transplantation,

Completed
  • Chronic Myeloproliferative Disorders
  • +5 more
  • filgrastim
  • +2 more
  • Seattle, Washington
  • +15 more
Mar 4, 2014

Chronic Myeloproliferative Disorders, Kidney Cancer, Leukemia Trial in San Francisco, Winston-Salem (biological, drug,

Unknown status
  • Chronic Myeloproliferative Disorders
  • +6 more
  • anti-thymocyte globulin
  • +12 more
  • San Francisco, California
  • +1 more
Jan 3, 2014

Chronic Myeloproliferative Disorders, Drug/Agent Toxicity by Tissue/Organ, Leukemia Trial in Cleveland (sargramostim, amifostine

Unknown status
  • Chronic Myeloproliferative Disorders
  • +7 more
  • sargramostim
  • +3 more
  • Cleveland, Ohio
    Cleveland Clinic Cancer Center
Dec 18, 2013

Chronic Myeloproliferative Disorders, Kidney Cancer, Leukemia Trial in Milwaukee (management of therapy complications, pain

Unknown status
  • Chronic Myeloproliferative Disorders
  • +11 more
  • management of therapy complications
  • pain therapy
  • Milwaukee, Wisconsin
    Medical College of Wisconsin Cancer Center
Sep 19, 2013

Chronic Myeloproliferative Disorders, Leukemia, MDS Trial in Philadelphia (biological, dietary supplement, drug, procedure)

Completed
  • Chronic Myeloproliferative Disorders
  • +3 more
  • filgrastim
  • +9 more
  • Philadelphia, Pennsylvania
  • +1 more
Jun 25, 2013

Anxiety Disorder, Chronic Myeloproliferative Disorders, Depression Trial in New York (pain therapy, psychosocial assessment and

Completed
  • Anxiety Disorder
  • +6 more
  • pain therapy
  • psychosocial assessment and care
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 17, 2013

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in New York (pyroxamide)

Completed
  • Chronic Myeloproliferative Disorders
  • +7 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 4, 2013

Chronic Myeloproliferative Disorders, Leukemia, Myelodysplastic/Myeloproliferative Diseases Trial run by the NHLBI

Terminated
  • Chronic Myeloproliferative Disorders
  • +2 more
  • Bethesda, Maryland
    NIH - Warren Grant Magnuson Clinical Center
Apr 30, 2013

Studying Fentanyl in Patients With Cancer

Terminated
  • Brain and Central Nervous System Tumors
  • +10 more
  • fentanyl citrate
  • pharmacological study
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Apr 16, 2013

Chronic Myeloproliferative Disorders, Infection, Leukemia Trial in United States (amphotericin B deoxycholate, nystatin)

Completed
  • Chronic Myeloproliferative Disorders
  • +5 more
  • Phoenix, Arizona
  • +58 more
Mar 25, 2013

Breast Cancer, Chronic Myeloproliferative Disorders, GTD Trial in Zion (aldesleukin, recombinant interferon alfa, sargramostim)

Completed
  • Breast Cancer
  • +11 more
  • aldesleukin
  • +2 more
  • Zion, Illinois
    Midwestern Regional Medical Center
Mar 25, 2013